Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Dose-Response Relationship: Overview

Dose-Response Relationship: Overview

Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...

Dose-Response Relationship: Potency and Efficacy

Dose-Response Relationship: Potency and Efficacy

The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it produces...

Pharmacokinetic–Pharmacodynamic Relationship: Dose to Pharmacological Effect

Pharmacokinetic–Pharmacodynamic Relationship: Dose to Pharmacological Effect

A drug’s dosage and pharmacokinetic properties determine how quickly it acts, how intense its effects are, and how long it lasts. Higher doses increase drug concentration at receptor sites, producing a hyperbolic curve when pharmacologic response is plotted against drug dose. Converting this scale to a log-linear format results in a sigmoidal curve, better representing dose–response relationships.For drugs following a one-compartment model, the pharmacologic response is directly proportional to...

Pharmacokinetic–Pharmacodynamic Relationship: Intensity of Dose-Effect Relationship

Pharmacokinetic–Pharmacodynamic Relationship: Intensity of Dose-Effect Relationship

Pharmacodynamics explores the relationship between drug concentration and its effect. In a quantal response drug, the duration of action better correlates with drug concentration, while for graded effect drugs, the intensity of response is more relevant. This intensity depends on the dose, drug removal rate, and the region of the concentration–response curve.The concentration–response curve can be divided into three regions. Region 3 (80–100% maximum response) demonstrates that even as drug...

Pharmacodynamic Models: Additive and Proportional Drug Effect Model

Pharmacodynamic Models: Additive and Proportional Drug Effect Model

Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...

Dose Response Curve: Conventional Versus Nonmonotonic

Dose Response Curve: Conventional Versus Nonmonotonic

The correlation between a drug's dosage and its impact on a biological system is a cornerstone of pharmacology and toxicology. Conventional dose–response curves, which include graded and quantal relationships, are key to this understanding. Graded dose–response curves depict the spectrum of a biological reaction to different doses within an individual, indicating that as the drug dosage increases, so does the intensity of the response. On the other hand, quantal dose–response relationships...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Matching One Sample According to Two Criteria in Observational Studies.

Journal of the American Statistical Association·2023

Same author

Selecting appropriate controls for kidney donors--reply.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2014

Same author

Mortality and cardiovascular disease among older live kidney donors.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2014

Same author

Pediatric care for preterm infants after NICU discharge: high number of office visits and prescription medications.

Journal of perinatology : official journal of the California Perinatal Association·2008

Same author

Predicting cisplatin ototoxicity in children: the influence of age and the cumulative dose.

European journal of cancer (Oxford, England : 1990)·2004

Same author

Matching and thick description in an observational study of mortality after surgery.

Biostatistics (Oxford, England)·2003

Search research articles

Related Experiment Video

Updated: Jul 10, 2026

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents (HPHC)

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents (HPHC)

Published on: May 10, 2016

Marginal analysis applied to the dose-response curve.

J H Silber¹, H Kaizer

¹Division of Pediatric Oncology, Children's Hospital, Philadelphia, PA 19104.

Medical and Pediatric Oncology

|January 1, 1988

Summary

Marginal analysis, an economic tool, can optimize drug dosage by balancing efficacy and side effects. Applying this method may improve patient survival and therapeutic success in clinical settings.

Area of Science:

Pharmacoeconomics
Clinical Pharmacology
Oncology

Background:

Drug dosage decisions significantly impact therapeutic success and patient survival.
Traditional methods may not fully optimize the balance between drug efficacy and adverse effects.
The dose-response curve is central to understanding drug effects but requires sophisticated analytical approaches.

Purpose of the Study:

To introduce and adapt the economic principle of marginal analysis for clinical drug dosage determination.
To demonstrate how marginal analysis can optimize the balance between drug efficacy and side effects.
To illustrate the application of marginal analysis using a specific chemotherapy example.

Main Methods:

Defining and explaining the concept of marginal analysis from economics.

More Related Videos

Parallel Interrogation of β-Arrestin2 Recruitment for Ligand Screening on a GPCR-Wide Scale using PRESTO-Tango Assay

Parallel Interrogation of β-Arrestin2 Recruitment for Ligand Screening on a GPCR-Wide Scale using PRESTO-Tango Assay

Published on: March 10, 2020

Comprehensive Analysis of Drug Response using the FLICK Assay

Comprehensive Analysis of Drug Response using the FLICK Assay

Published on: June 6, 2025

Related Experiment Videos

Last Updated: Jul 10, 2026

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents (HPHC)

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents (HPHC)

Published on: May 10, 2016

Parallel Interrogation of β-Arrestin2 Recruitment for Ligand Screening on a GPCR-Wide Scale using PRESTO-Tango Assay

Parallel Interrogation of β-Arrestin2 Recruitment for Ligand Screening on a GPCR-Wide Scale using PRESTO-Tango Assay

Published on: March 10, 2020

Comprehensive Analysis of Drug Response using the FLICK Assay

Comprehensive Analysis of Drug Response using the FLICK Assay

Published on: June 6, 2025

Redefining marginal analysis for the clinical context of dose determination.

Applying the redefined marginal analysis to adjuvant adriamycin chemotherapy in osteosarcoma.

Main Results:

The application of marginal analysis provides a framework for optimizing drug dosage decisions.
Failure to use marginal analysis may lead to suboptimal therapeutic outcomes and patient survival.
The proposed method is adaptable to various dosing problems beyond chemotherapy.

Conclusions:

Marginal analysis offers a valuable tool for enhancing drug dosage strategies in clinical practice.
Implementing marginal analysis can potentially improve overall therapeutic success and patient survival rates.
The technique has broad applicability and implications for future clinical trial designs and dose-response estimation.